021-51111890
购物车（）
sales@molnova.cn
Loxapine succinate
CAS No. 27833-64-3
Loxapine succinate ( CL 71,563 )
产品货号. M13849 CAS No. 27833-64-3
A typical antipsychotic agent that displays an extremely strong binding affinity for dopamine D4 and serotonin 5-HT2 receptors.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ￥267 | 有现货 |
|
| 100MG | ￥381 | 有现货 |
|
| 200MG | ￥616 | 有现货 |
|
| 500MG | ￥1353 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Loxapine succinate
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述A typical antipsychotic agent that displays an extremely strong binding affinity for dopamine D4 and serotonin 5-HT2 receptors.
-
产品描述A typical antipsychotic agent that displays an extremely strong binding affinity for dopamine D4 and serotonin 5-HT2 receptors.Schizophrenia Approved
-
同义词CL 71,563
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT2(bovine);5-HT2(human);D2;D4
-
研究领域Neurological Disease
-
适应症Schizophrenia
化学信息
-
CAS Number27833-64-3
-
分子量445.90
-
分子式C22H24ClN3O5
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESCN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O
-
化学全称Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Singh AN, et al. J Psychiatry Neurosci. 1996 Jan;21(1):29-35.
2. Labuzek K, et al. Eur Neuropsychopharmacol. 2005 Jan;15(1):23-30.
3. Lee T, et al. Psychiatry Res. 1984 Aug;12(4):277-85.
2. Labuzek K, et al. Eur Neuropsychopharmacol. 2005 Jan;15(1):23-30.
3. Lee T, et al. Psychiatry Res. 1984 Aug;12(4):277-85.
产品手册
关联产品
-
cis-Urocanic acid
cis-Urocanic acid is a 5-HT2A receptor agonist (Kd: 4.6 nM). It is an immune modulator that induces immunosuppression by binding to the 5-HT2A receptor.
-
RG2833
RG2833 (RGFP109), a brain-penetrant HDAC inhibitor, is with IC50 of 60 nM and 50 nM for HDAC1 and HDAC3, respectively.
-
Nelotanserin
A potent, selective 5-HT2A inverse agonist with pKi of 9.2; displays >30- and 5000-fold selectivity compared with 5-HT2C and 5-HT2B receptors.
